Pillstats
Rx only · Injection, Solution · Intravenous

Regadenoson

Brands: Lexiscan · Regadenoson

12 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US13 NDCs
12 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)1650543
US makers12 labelers
Packages13
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

22K44K66K89K2025 Q12025 Q22025 Q32025 Q42026 Q1
54K
Rx · 2026 Q1
266K
Units dispensed
-30%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it12 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Apotex Corp.unknown2SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING
Kanchan Healthcare Incunknown1SUPPLYING
Accord Healthcare Inc.unknown1SUPPLYING
Baxter Healthcare Corporationunknown1SUPPLYING
Marlex Pharmaceuticals Incunknown1SUPPLYING
Hospira, Inc.unknown1SUPPLYING
Gland Pharma Limitedunknown1SUPPLYING
Meitheal Pharmaceuticals Inc.unknown1SUPPLYING
Astellas Pharma US, Inc.unknown1SUPPLYING
International Medication Systems, Limitedunknown1SUPPLYING
Indies Pharma Jamaica Limitedunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 30, 2024
    RECALLRecall (Class II): Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter P…

    Labeling: Missing Label — Recalling firm: Baxter Healthcare Corporation — Nationwide within the USA